Mexico participating in three virus vaccine trials

Mexico's Secretary of Foreign Relations Marcelo Ebrard on Tuesday said the government has agreements with three companies to carry out advanced clinical trials for potential COVID-19 vaccines in Mexico this fall.

Ebrard said that Mexico had memoranda of understanding with Janssen Pharmaceuticals of the United States and the Chinese companies Cansino Biologics and Walvax Biotechnology.

He said the agreements would guarantee Mexico's access to a vaccine if they prove successful.

Ebrard added that the trials would be carried out between September and January.

In total, Mexico is talking to 15 companies about potential trials.